15.3% Below Target

DexCom, Inc. (DXCM) has a consensus 12-month price target of $83.56, implying 15.3% upside from $72.47. The 52 analysts covering DXCM see moderate appreciation potential.

DXCM has a consensus rating of "Buy" based on 52 Wall Street analysts. The rating breakdown is predominantly bullish, with 42 Buy/Strong Buy ratings. The consensus 12-month price target of $83.56 implies 15.3% upside from current levels.

DXCM trades at a forward P/E of 27.9818x, representing a moderate valuation. With analysts targeting $83.56 (15.3% implied move), the stock appears reasonably valued with upside.

The most bullish Wall Street analyst has a price target of $95 for DXCM, while the most conservative target is $64. The consensus of $83.56 represents the median expectation. Our quantitative valuation model projects a bull case target of $130 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.

DXCM is heavily covered by Wall Street, with 52 analysts providing price targets and ratings. Of these, 1 have Strong Buy ratings, 41 have Buy ratings, 8 recommend Hold, and 2 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

The 12-month DXCM stock forecast based on 52 Wall Street analysts shows a consensus price target of $83.56, with estimates ranging from $64 (bear case) to $95 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $98, with bear/bull scenarios of $62/$130.

Our quantitative valuation model calculates DXCM's fair value at $98 (base case), with a bear case of $62 and bull case of $130. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 62/100.

DXCM trades at a forward P/E ratio of 28.0x based on next-twelve-months earnings estimates compared to a trailing P/E of 34.7x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

Wall Street analysts are optimistic on DXCM, with a "Buy" consensus rating and $83.56 price target (15.3% upside). 42 of 52 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

DXCM analyst price targets range from $64 to $95, a 37% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $83.56 consensus represents the middle ground. Our model's $62-$130 range provides an independent fundamental perspective.